Target Price | $31.62 |
Price | $22.84 |
Potential |
38.44%
register free of charge
|
Number of Estimates | 11 |
11 Analysts have issued a price target BioLife Solutions, Inc. 2026 .
The average BioLife Solutions, Inc. target price is $31.62.
This is
38.44%
register free of charge
$35.70
56.30%
register free of charge
$30.30
32.66%
register free of charge
|
|
A rating was issued by 15 analysts: 14 Analysts recommend BioLife Solutions, Inc. to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the BioLife Solutions, Inc. stock has an average upside potential 2026 of
38.44%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 82.25 | 99.70 |
8.42% | 21.22% | |
EBITDA Margin | -5.34% | 20.93% |
79.67% | 492.14% | |
Net Margin | -24.53% | -4.70% |
72.63% | 80.84% |
11 Analysts have issued a sales forecast BioLife Solutions, Inc. 2025 . The average BioLife Solutions, Inc. sales estimate is
This results in the following potential growth metrics:
7 Analysts have issued an BioLife Solutions, Inc. EBITDA forecast 2025. The average BioLife Solutions, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
11 BioLife Solutions, Inc. Analysts have issued a net profit forecast 2025. The average BioLife Solutions, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -0.43 | -0.10 |
72.26% | 76.74% | |
P/E | negative | |
EV/Sales | 10.14 |
11 Analysts have issued a BioLife Solutions, Inc. forecast for earnings per share. The average BioLife Solutions, Inc. EPS is
This results in the following potential growth metrics and future valuations:
BioLife Solutions, Inc....
Analyst | Rating | Action | Date |
---|---|---|---|
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | May 13 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 06 2025 |
Northland Capital Markets |
Locked
➜
Locked
|
Locked | Jan 08 2025 |
Benchmark |
Locked
➜
Locked
|
Locked | Dec 19 2024 |
Keybanc |
Locked
➜
Locked
|
Locked | Dec 13 2024 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 18 2024 |
Craig-Hallum |
Locked
➜
Locked
|
Locked | Nov 13 2024 |
Analyst Rating | Date |
---|---|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
May 13 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 06 2025 |
Locked
Northland Capital Markets:
Locked
➜
Locked
|
Jan 08 2025 |
Locked
Benchmark:
Locked
➜
Locked
|
Dec 19 2024 |
Locked
Keybanc:
Locked
➜
Locked
|
Dec 13 2024 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 18 2024 |
Locked
Craig-Hallum:
Locked
➜
Locked
|
Nov 13 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.